Literature DB >> 15888939

Murine model of invasive aspergillosis.

Russell E Lewis1, Nathan P Wiederhold.   

Abstract

The growing importance of infectious caused by Aspergillus species during the last decade has created a need for practical and reproducible animal models of invasive aspergillosis suitable for studying fungal virulence, infection pathogenesis, diagnostic markers, and testing of antifungal therapy. Murine models remain the most commonly used models for studying aspergillosis because of their ease of manipulation and the large number of reagents available for studying disease-host responses. This chapter provides describes a murine model of invasive aspergillosis suitable for basic and translational studies of invasive pulmonary aspergillosis and highlights experimental variables that affect the course and reproducibility of infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888939     DOI: 10.1385/1-59259-943-5:129

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  17 in total

1.  Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis.

Authors:  Russell E Lewis; Nathaniel D Albert; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

2.  Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice.

Authors:  Russell E Lewis; Georgios Chamilos; Randall A Prince; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

3.  Cutaneous model of invasive aspergillosis.

Authors:  Ronen Ben-Ami; Russell E Lewis; Konstantinos Leventakos; Jean-Paul Latgé; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

4.  Treatment of Cyclosporin A retains host defense against invasive pulmonary aspergillosis in a non-immunosuppressive murine model by preserving the myeloid cell population.

Authors:  Sarah Sze Wah Wong; Orhan Rasid; Paris Laskaris; Arnaud Fekkar; Jean-Marc Cavaillon; William J Steinbach; Oumaima Ibrahim-Granet
Journal:  Virulence       Date:  2017-07-06       Impact factor: 5.882

Review 5.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

6.  Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis.

Authors:  Russell E Lewis; Konstantinos Leventakos; Guangling Liao; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

7.  Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.

Authors:  Russell E Lewis; Guangling Liao; Jinggou Hou; Georgios Chamilos; Randall A Prince; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

8.  Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.

Authors:  Gerardo Quezada; Nadezhda V Koshkina; Patrick Zweidler-McKay; Zichao Zhou; Dimitrios P Kontoyiannis; Eugenie S Kleinerman
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

9.  Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.

Authors:  Russell E Lewis; Nathan D Albert; Guangling Liao; Jingguo Hou; Randall A Prince; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

10.  Antifungal Activity of Leaves of Mangroves Plant Acanthus licifolius Against Aspergillus fumigatus.

Authors:  P S Kalaskar; V V Karande; A S Bannalikar; M M Gatne
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.